K22.7 Barrett's esophagus

Name of the Condition

• Barrett's esophagus

Summary

Barrett's esophagus is a condition where the normal lining of the esophagus is replaced by tissue similar to the intestinal lining, a process called intestinal metaplasia. This change is often associated with chronic gastroesophageal reflux disease (GERD) and may increase the risk of esophageal adenocarcinoma. The condition is typically diagnosed during endoscopic evaluation for reflux symptoms.

Causes

The primary cause of Barrett's esophagus is chronic exposure of the esophageal lining to stomach acid and bile, most commonly due to GERD. Long-term acid reflux damages the esophageal epithelium, leading to cellular changes. Other factors, such as obesity and hiatal hernia, may contribute to increased acid exposure and subsequent tissue transformation.

Risk Factors

• Chronic gastroesophageal reflux disease (GERD)
• Obesity, particularly abdominal obesity
• Male gender
• Age (more common in adults over 50)
• Tobacco use
• Family history of Barrett's esophagus or esophageal cancer

Symptoms

• Chronic heartburn or acid reflux
• Difficulty swallowing (dysphagia)
• Chest pain unrelated to heartburn
• Regurgitation of food or liquid
• Unexplained weight loss (in advanced cases)

Diagnosis

Diagnosis involves an upper endoscopy with biopsy to confirm intestinal metaplasia. During the procedure, the esophagus is visually inspected for changes in the lining, and tissue samples are taken to evaluate cellular changes. Additional tests, such as pH monitoring or manometry, may assess reflux severity or esophageal function.

Treatment Options

• Proton pump inhibitors (PPIs) to reduce acid production and manage GERD symptoms
• Endoscopic therapies (e.g., radiofrequency ablation, cryotherapy) to remove or destroy abnormal tissue
• Surveillance endoscopies to monitor for dysplasia or cancer
• Lifestyle modifications to reduce reflux triggers

Prognosis and Follow-Up

With proper management, the risk of progression to cancer is low, but regular surveillance is recommended. Follow-up intervals depend on the presence and grade of dysplasia. Most patients with no dysplasia undergo repeat endoscopy every 3–5 years, while those with low-grade dysplasia may be monitored more frequently.

Complications

• Esophageal adenocarcinoma (rare but increased risk)
• Strictures or narrowing of the esophagus
• Bleeding from esophageal ulcers
• Persistent GERD symptoms despite treatment

Lifestyle & Prevention

• Maintain a healthy weight to reduce abdominal pressure
• Avoid trigger foods (e.g., spicy, fatty, or acidic items)
• Elevate the head of the bed to minimize nighttime reflux
• Quit smoking and limit alcohol consumption
• Eat smaller, more frequent meals

When to Seek Professional Help

Seek medical attention if you experience persistent heartburn, difficulty swallowing, unexplained weight loss, or chest pain. These symptoms may indicate complications or progression of Barrett's esophagus.

Tips for Medical Coders

Document the presence of intestinal metaplasia confirmed by biopsy. Include details of endoscopic findings, such as the extent of affected esophagus (e.g., circumferential vs. segmental) and any dysplasia. Note associated conditions like GERD or hiatal hernia to support coding accuracy. Ensure documentation aligns with clinical guidelines for surveillance and management.